| Literature DB >> 34196299 |
Florian Sicklinger1,2, Ingmar Sören Meyer1,2, Xue Li1,2, Daniel Radtke3, Severin Dicks4,5, Moritz P Kornadt1,2, Christina Mertens6, Julia K Meier7, Kory J Lavine8, Yunhang Zhang1,2, Tim Christian Kuhn1,2, Tobias Terzer9, Jyoti Patel1,2, Melanie Boerries4,10, Gabriele Schramm11, Norbert Frey1,2, Hugo A Katus1,2, David Voehringer3, Florian Leuschner1,2.
Abstract
The inflammatory response after myocardial infarction (MI) is a precisely regulated process that greatly affects subsequent remodeling. Here, we show that basophil granulocytes infiltrated infarcted murine hearts, with a peak occurring between days 3 and 7. Antibody-mediated and genetic depletion of basophils deteriorated cardiac function and resulted in enhanced scar thinning after MI. Mechanistically, we found that basophil depletion was associated with a shift from reparative Ly6Clo macrophages toward increased numbers of inflammatory Ly6Chi monocytes in the infarcted myocardium. Restoration of basophils in basophil-deficient mice by adoptive transfer reversed this proinflammatory phenotype. Cellular alterations in the absence of basophils were accompanied by lower cardiac levels of IL-4 and IL-13, two major cytokines secreted by basophils. Mice with basophil-specific IL-4/IL-13 deficiency exhibited a similarly altered myeloid response with an increased fraction of Ly6Chi monocytes and aggravated cardiac function after MI. In contrast, IL-4 induction in basophils via administration of the glycoprotein IPSE/α-1 led to improved post-MI healing. These results in mice were corroborated by the finding that initially low counts of blood basophils in patients with acute MI were associated with a worse cardiac outcome after 1 year, characterized by a larger scar size. In conclusion, we show that basophils promoted tissue repair after MI by increasing cardiac IL-4 and IL-13 levels.Entities:
Keywords: Cardiology; Cardiovascular disease; Heart failure; Innate immunity
Mesh:
Substances:
Year: 2021 PMID: 34196299 PMCID: PMC8245180 DOI: 10.1172/JCI136778
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808